Revenue Growth Acceleration
Total revenue grew 20.9% YoY to $1,272.7M in Q1 FY2026, up from $1,052.9M in the prior-year period, reflecting strong demand across Incyte's product portfolio.
INCYTE CORP is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: Incyte Corporation delivered a strong Q1 FY2026, with revenue surging 20.9% YoY to $1.27B and net income nearly doubling to $303.3M, driven by robust product sales and disciplined cost management.
Drawn from management commentary in the Q1 2026 10-Q:
Total revenue grew 20.9% YoY to $1,272.7M in Q1 FY2026, up from $1,052.9M in the prior-year period, reflecting strong demand across Incyte's product portfolio.
Operating income jumped 46.8% YoY to $301.1M, with operating margin expanding approximately 410 basis points to 23.7%, demonstrating meaningful operating leverage as revenue growth outpaced expense growth.
R&D expenses increased 18.0% YoY to $515.9M, representing approximately 40.5% of revenue, underscoring Incyte's continued commitment to pipeline development even as profitability improves.
Revenue
$1.27B
++20.87% YoY
EPS (Basic)
$1.52
++85.37% YoY
Operating Income
$301.12M
++46.77% YoY
Add INCY to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.